CONCORD BIOTECH LIMITEDCONCORDBIO

Concord Biotech Acquires Stake in Renewable Power Firm FSGE

Concord Biotech shares gain 5% after bagging USFDA approval for $500 million drug

Concord Biotech shares gain 6% after USFDA nod for $30 million size immunosuppressant drug

Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil

Concord Biotech Q4 profit slides 37%, margins shrink; declares ₹7.55 dividend